Rare hereditary systemic disease with peripheral neuropathy

Rare hereditary systemic disease with peripheral neuropathy (Orphanet code 207021) is a broad classification category within Orphanet that encompasses a group of inherited conditions in which a systemic disease process — affecting multiple organ systems — is accompanied by peripheral neuropathy as a significant clinical feature. Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves, which can cause numbness, tingling, pain, and weakness, typically in the hands and feet. Because this is a grouping category rather than a single discrete disease entity, the specific clinical features, affected organ systems, genetic causes, and severity vary widely depending on the underlying condition classified within this group. Conditions falling under this umbrella may include hereditary amyloidoses (such as transthyretin-related familial amyloid polyneuropathy), Fabry disease, familial forms of porphyria, and other multisystem inherited disorders where peripheral nerve involvement is a prominent component alongside involvement of organs such as the heart, kidneys, liver, gastrointestinal tract, skin, or eyes. Symptoms beyond neuropathy may include organ dysfunction, autonomic disturbances (such as abnormal blood pressure regulation, gastrointestinal dysmotility, or sweating abnormalities), and progressive systemic deterioration. Treatment depends entirely on the specific underlying diagnosis. Some conditions within this group now have disease-modifying therapies — for example, gene-silencing agents or stabilizer drugs for hereditary transthyretin amyloidosis, or enzyme replacement therapy for Fabry disease. Supportive care for neuropathic symptoms, including pain management and physical rehabilitation, is commonly employed across these conditions. Genetic testing and multidisciplinary care are essential for accurate diagnosis and optimal management.

Common questions about Rare hereditary systemic disease with peripheral neuropathy